The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Improving detection methods for PIK3CA mutations in breast cancer using peripheral blood from patients with metastastic breast cancer (MBC).
M. J. Higgins
No relevant relationships to disclose
D. Jelovac
No relevant relationships to disclose
E. Barnathan
No relevant relationships to disclose
B. Blair
No relevant relationships to disclose
S. Slater
No relevant relationships to disclose
P. Powers
No relevant relationships to disclose
J. Zorzi
No relevant relationships to disclose
S. C. Jeter
No relevant relationships to disclose
G. R. Oliver
No relevant relationships to disclose
F. Diehl
Employment or Leadership Position - ICU Medical
Stock Ownership - Inostics
P. Angenendt
Employment or Leadership Position - Inostics
P. Huang
No relevant relationships to disclose
P. Argani
No relevant relationships to disclose
K. Murphy
No relevant relationships to disclose
A. C. Wolff
No relevant relationships to disclose
B. H. Park
No relevant relationships to disclose